Brief: Silo Pharma Initiates Human Factor Study Of SPC-15 For The Treatment Of PTSD
11/10/2023 13:51
Oct 11 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA INITIATES HUMAN FACTOR STUDY OF SPC-15 FOR THE
TREATMENT OF PTSD
* SILO PHARMA INC - FIRST OF TWO-PART STUDY WAS LAUNCHED IN
OCTOBER, WITH EXPECTED COMPLETION OF THIS STUDY BEFORE YEAR END
2023
Source text for Eikon: ID:nGNX7G6kxY
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement